Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for reperfusion arrhythmia prevention in STEMI patients undergoing PPCI
IRCT20220723055534N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Aug 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) and arrhythmia comparing Colchicine with Placebo (2 arms). Primary endpoints: Initial TIMI flow of the involved vessel, Final TIMI flow of the involved vessel and 2 more. Started Aug 2022; status: completed.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)arrhythmia
Beyond the preview
Go deeper on IRCT20220723055534N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220723055534N1.